Comparison of two automated commercial assays for routine detection of anti-hepatitis E Virus IgM antibodies in clinical samples

Archive ouverte

Becquart, Adrien | Guigon, Aurelie | Regueme, Alexandre | Coulon, Pauline | Bocket, Laurence | Hober, Didier | Alidjinou, Enagnon Kazali

Edité par CCSD ; Elsevier -

International audience. Diagnosis of hepatitis E virus (HEV) infection relies first on detection of IgM antibodies (Ab), sometimes completed with HEV RNA detection. This study aimed to compare the performance of two automated anti-HEV IgM Ab assays. Correlation between Virclia® (Vircell) and Liaison® (Diasorin) assays was carried out on 178 routine clinical samples. Both assays were run on 67 samples from HEV RT-PCR (Altona) screened patients, and 52 Wantai® EIA (Euroimmun) tested samples. An excellent correlation was observed between both assays with an overall agreement of 96.6% (172/178), and a kappa coefficient at 0.93. In HEV RNA positive group (n=43), IgM detection rate was 93.3% (14/15) in immunocompetent patients, with both assays. In immunocompromised patients, detection rate was 75% (21/28) and 71.4% (20/28) using Virclia® and Liaison XL® assays, respectively. Virclia® and Liaison® anti-HEV IgM assays have similar performance for the detection of anti-HEV IgM Ab.

Consulter en ligne

Suggestions

Du même auteur

Oropharyngeal samples versus lesion specimens at diagnosis in patients infected with Monkeypox virus in Northern France.

Archive ouverte | Ouafi, Mahdi | CCSD

International audience. The ongoing outbreak of monkeypox virus (MPXV) is the largest one in historically non-endemic countries. Early reports described atypical epidemiological and clinical presentations. We invest...

Defective HIV-1 DNA pol sequences are not associated with HIV-1 DNA levels and drive most APOBEC-context drug resistance mutations

Archive ouverte | Alidjinou, Enagnon Kazali | CCSD

International audience. IntroductionThe specificity of HIV-1 DNA genotypic resistance tests (GRTs) is hampered by the detection of the APOBEC-context drug resistance mutations (AC DRMs), usually harboured by replica...

Emergence of Q493R mutation in SARS-CoV-2 spike protein during bamlanivimab/etesevimab treatment and resistance to viral clearance.

Archive ouverte | Guigon, Aurelie | CCSD

International audience

Chargement des enrichissements...